Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
|Poll|January 16, 2018
Mini Quiz: Motivational Pharmacotherapy
Motivational interviewing can be very useful for addressing patients' ambivalence about psychopharmacologic issues. Take the quiz and learn more.
Advertisement
Which of the following is NOT true of motivational pharmacotherapy?
Advertisement
Related to this article
Check out our pipeline updates from September!
Don't miss out on these CME articles! Test your knowledge here.
A cross-sector ACNP task force calls for shared standards and shared data to move psychiatry beyond trial-and-error prescribing.
Despite previous failure of PDE10A inhibitor drugs to demonstrate antipsychotic effects in clinical trials, a new "improved" iteration has met phase 2 trial endpoints.
Experts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.
Learn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.
Panelists explain why precision tools lag in schizophrenia care and highlight simple biomarkers, faster deals, and clinician-industry collaboration.
Advertisement
Advertisement
Trending on Psychiatric Times
1
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
2
Rapid Antidepressants and Suicide Risk: What Do We Really Know?
3
Why Diagnosis Remains Psychiatry's Hardest Task in MDD
4
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
5